Bill Text: TX SB136 | 2027-2028 | 90th Legislature Regular Session | Introduced
Bill Title: Relating to Medicaid coverage and reimbursement for seizure detection devices and a public awareness campaign related to those devices.
Sponsorship: Partisan Bill (Democrat 1)
Status: (Introduced) 2026-11-09 - Filed [SB136 Detail]
Download: Texas-2027-SB136-Introduced.html
| 90R1840 AB-D | ||
| By: Menéndez | S.B. No. 136 | |
|
|
||
|
|
||
| relating to Medicaid coverage and reimbursement for seizure | ||
| detection devices and a public awareness campaign related to those | ||
| devices. | ||
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
| SECTION 1. Subchapter B, Chapter 32, Human Resources Code, | ||
| is amended by adding Section 32.03142 to read as follows: | ||
| Sec. 32.03142. SEIZURE DETECTION DEVICES; AWARENESS | ||
| CAMPAIGN. (a) In this section, "seizure detection device" means a | ||
| telemonitoring device approved by the United States Food and Drug | ||
| Administration, including any related service or subscription that | ||
| supports the device's prescribed use, that: | ||
| (1) provides ongoing patient monitoring and alert | ||
| services to detect seizure activity; | ||
| (2) transmits notice of a patient's seizure activity | ||
| to a caregiver for appropriate medical response; or | ||
| (3) collects data on a patient's seizure activity for a | ||
| health care provider to diagnose or appropriately treat a health | ||
| care condition causing the seizure activity. | ||
| (b) The commission shall ensure medical assistance | ||
| reimbursement is provided to cover in full the cost of a seizure | ||
| detection device for a medical assistance recipient if the | ||
| recipient's health care provider determines the device: | ||
| (1) is medically appropriate based on the recipient's | ||
| medical condition or status; and | ||
| (2) will likely: | ||
| (A) assist in reducing bodily harm to or death of | ||
| the recipient as a result of a seizure; or | ||
| (B) provide data to the health care provider | ||
| necessary to appropriately diagnose or treat the recipient's health | ||
| condition causing the seizure activity. | ||
| (c) For purposes of providing reimbursement under this | ||
| section, a seizure detection device is durable medical equipment | ||
| and the commission shall ensure the reimbursement rate for related | ||
| service and subscription fees is at least equal to the | ||
| reimbursement rate for home telemonitoring services under | ||
| Subchapter F, Chapter 548, Government Code. | ||
| (d) The commission shall conduct a biennial review of the | ||
| seizure detection devices covered under this section and update the | ||
| list of covered devices as necessary based on technology | ||
| advancements and guidance issued by the United States Food and Drug | ||
| Administration. | ||
| (e) The commission shall implement a statewide public | ||
| awareness campaign to educate health care providers, medical | ||
| assistance recipients, and the general public on the availability, | ||
| benefits, and coverage of seizure detection devices and related | ||
| services and subscriptions under this section. | ||
| (f) The campaign under Subsection (e) must be designed to: | ||
| (1) clearly inform health care providers and | ||
| recipients that the full cost of seizure detection devices and | ||
| related services and subscriptions for the device's use are | ||
| reimbursable under this section; | ||
| (2) emphasize the ability of seizure detection devices | ||
| to help reduce the risk of seizure-related injuries and enhance the | ||
| quality of life for individuals living with epilepsy and their | ||
| families; | ||
| (3) provide essential information on sudden, | ||
| unexpected death from epilepsy, including the associated risks and | ||
| how seizure detection devices reduce the risk of sudden, unexpected | ||
| death from epilepsy by enabling timely intervention during | ||
| seizures; and | ||
| (4) provide resources for further education and | ||
| support for those at risk of sudden, unexpected death from | ||
| epilepsy. | ||
| SECTION 2. If before implementing any provision of this Act | ||
| a state agency determines that a waiver or authorization from a | ||
| federal agency is necessary for implementation of that provision, | ||
| the agency affected by the provision shall request the waiver or | ||
| authorization and may delay implementing that provision until the | ||
| waiver or authorization is granted. | ||
| SECTION 3. This Act takes effect September 1, 2027. | ||
